Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
30 Sep 2013
Vectura and UCB to collaborate and share expertise in severe inflammatory disease
Read More
27 Sep 2013
UCB completes institutional Eurobond offering
Read More
27 Sep 2013
UCB launches institutional Eurobond offering
Read More
20 Sep 2013
Results of the public exchange offer on the bonds maturing in November 2014
Read More
20 Sep 2013
UCB receives CHMP positive opinion for Cimzia® in severe active axial spondyloarthritis
Read More
18 Sep 2013
Acquisition of own shares
Read More
3 Sep 2013
UCB launches a public exchange offer on its bonds maturing in November 2014
Read More
3 Sep 2013
UCB files a public exchange offer on its bonds maturing in November 2014
Read More
31 Jul 2013
UCB Half Year Report 2013: UCB reports continued strong growth of core medicines and confirms 2013 financial targets
Read More
30 Jul 2013
Transparency notification of The Capital Group Companies Inc.
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
50
Page
51
Page
52
Page
53
Current page
54
Page
55
Page
56
Page
57
Page
58
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss